Nevertheless, since HER2 cell surface expression per se is not restricted to tumor cells, unwanted “bystander” effects can occur, and cardiotoxicity arising from heart HER2 expression is a well-characterized deleterious trastuzumab side effect (30, 31). Here, ERBB2 is linked to neoplasm.